Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

211

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

211 results for “autoantibodies”

Learn how ShareScore rates datasets ↗
zenodo36/100

Dataset related to the article "Cardiac Biomarkers and Autoantibodies in Endurance Athletes: Potential Similarities with Arrhythmogenic Cardiomyopathy Pathogenic Mechanisms"

<p>This record contains raw data related to the article &ldquo;Cardiac Biomarkers and Autoantibodies in Endurance Athletes: Potential Similarities with Arrhythmogenic Cardiomyopathy Pathogenic Mechanisms&quot;.&nbsp;</p> <p>The &quot;Extreme Exercise Hypothesis&quot; states that when individuals perform training beyond the ideal exercise dose, a decline in the beneficial effects of physical activity occurs. This is due to significant changes in myocardial structure and function, such as hemodynamic alterations, cardiac chamber enlargement and hypertrophy, myocardial inflammation, oxidative stress, fibrosis, and conduction changes. In addition, an increased amount of circulating biomarkers of exercise-induced damage has been reported. Although these changes are often reversible, long-lasting cardiac damage may develop after years of intense physical exercise. Since several features of the athlete&#39;s heart overlap with arrhythmogenic cardiomyopathy (ACM), the syndrome of &quot;exercise-induced ACM&quot; has been postulated. Thus, the distinction between ACM and the athlete&#39;s heart may be challenging. Recently, an autoimmune mechanism has been discovered in ACM patients linked to their characteristic junctional impairment. Since cardiac junctions are similarly impaired by intense physical activity due to the strong myocardial stretching, we propose in the present work the novel hypothesis of an autoimmune response in endurance athletes. This investigation may deepen the knowledge about the pathological remodeling and relative activated mechanisms induced by intense endurance exercise, potentially improving the early recognition of whom is actually at risk.</p>

opencc-by-4.0Jul 2021View details →
dryad36/100

Data from: Docosahexaenoic acid intake suppresses acute silica-induced inflammation, autoantibody production, and autoimmune-related gene expression in lupus-prone mice

<p class="MsoNormal">Short-term repeated intranasal exposure crystalline silica (cSiO<sub>2</sub>), a known human autoimmune trigger, induces uncontrolled inflammation, upregulated IFN-stimulated gene expression, diverse autoantibody production, and glomerulonephritis in lupus-prone female NZBWF1 mice. Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA) prevents subchronic cSiO<sub>2</sub> triggering of these lupus hallmarks. To understand how this intervention impacts acute effects of cSiO<sub>2</sub>, we fed NZBWF1 mice control (CON) or DHA-containing diet, subjected them to a single acute intranasal instillation of 2.5 mg cSiO<sub>2</sub>, then compared pulmonary inflammatory/autoimmune responses and autoimmune-related gene expression in experimental cohorts terminated at 7 and 28 d post-instillation (PI). Acute cSiO<sub>2 </sub>exposure of CON-fed mice elicited decreased macrophage and increased neutrophil numbers at 7 d PI, whereas at 28 d PI, CON-fed mice treated with particle displayed elevated total cell, macrophage, neutrophil, and lymphocyte counts. In contrast, DHA-fed mice treated with cSiO<sub>2</sub> exhibited less macrophage loss at 7 d PI and reduced total cell, macrophage, and lymphocyte accumulation at 28 d PI. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) of lung sections suggested that cSiO<sub>2</sub> induced more robust cell death at 7 d PI in CON-fed than DHA-fed mice. Targeted multiplex ELISA of lung extracts showed that at 28 d PI, cSiO<sub>2</sub> induced higher concentrations of inflammation-associated cytokines (IL-1α, IL-6, and GM-CSF) and IFN-stimulated chemokines (CCL2, CCL3, CXCL10) in the CON-fed cohort than in the DHA-fed cohort. Autoantigen protein microarray of BALF collected at 28 d PI indicated that cSiO<sub>2</sub> induced higher autoantibody responses for representative nuclear, ribosomal, mitochondrial, and complement proteins in CON-fed mice than DHA-fed mice. Gene expression analyses with NanoString Autoimmune Gene Expression assay revealed greater cSiO<sub>2</sub>-triggered upregulation of genes associated with TLR activation, DNA signaling, proinflammatory cytokines,  chemokines, type 1 and 2 IFN response signatures, lymphocyte trafficking, MHC class 1 antigen presentation, B and T cell activation at 7 and 28 d PI in CON-fed mice than those fed DHA. Ingenuity Pathway Analysis (IPA) further demonstrated that DHA supplementation quelled cSiO<sub>2</sub>-induced responses top upstream regulators of proinflammatory and IFN-regulated gene networks to observed in CON-fed mice. Altogether, this short-term model illustrated that DHA suppression of aberrant acute cSiO<sub>2</sub>-induced inflammation is linked to altered regulation of autoimmune-related gene expression in lupus-prone mice.</p>

opencc-zeroMay 2023View details →
dryad36/100

Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes

<p>While cystic fibrosis (CF) lung disease is characterized by persistent inflammation and infections, and chronic inflammatory diseases are often accompanied by autoimmunity, autooimmune reactivity in CF has not been studied in depth. In this work, we undertook an unbiased approach to explore the systemic autoantibody repertoire in CF. Our results show higher levels of several new autoantibodies in the blood of people with CF (PwCF) compared to control subjects. Some of these are IgA autoantibodies targeting neutrophil components or autoantigens linked to neutrophil-mediated tissue damage in CF. We also found that PwCF with higher systemic IgM autoantibody levels have lower prevalence of <em>S. aureus</em> infection. On the other hand, IgM autoantibody levels in <em>S. aureus</em>-infected PwCF correlate with lung disease severity. Diabetic PwCF have significantly higher levels of IgA autoantibodies in their circulation compared to nondiabetic PwCF, and several of their IgM autoantibodies are associated with worse lung disease. In contrast, in nondiabetic PwCF blood levels of IgA autoantibodies correlate with lung disease. We have also identified other autoantibodies in CF that are associated with <em>P. aeruginosa</em> airway infection. In summary, we have identified several new autoantibodies and associations of autoantibody signatures with specific clinical features in CF.</p>

opencc-zeroAug 2023View details →
ClinicalTrials.gov36/100

Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

ClinicalTrials.gov study NCT03286556. IPD Sharing: NO. Countries: 1. Publications: 10.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies

ClinicalTrials.gov study NCT02387164. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3

ClinicalTrials.gov study NCT03401073. IPD Sharing: NO. Countries: 1. Publications: 15.

closedIPD-NOFeb 2026View details →
dryad36/100

Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes

Open the record for dataset details and reuse information.

publicAug 2023View details →
dryad36/100

Data from: Dietary docosahexaenoic acid supplementation inhibits acute pulmonary transcriptional and autoantibody responses to a single crystalline silica exposure in lupus-prone mice

Open the record for dataset details and reuse information.

publicJan 2024View details →
dryad36/100

Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq

Open the record for dataset details and reuse information.

publicNov 2022View details →
dryad36/100

Data from: Impact of soluble epoxide hydrolase inhibition on silica-induced pulmonary fibrosis, ectopic lymphoid neogenesis and autoantibody production in lupus-prone mice

Open the record for dataset details and reuse information.

publicJan 2025View details →
dryad36/100

Data from: Validation of a murine proteome-wide phage display library for identification of autoantibody specificities

Open the record for dataset details and reuse information.

publicFeb 2024View details →
dryad32/100

Autoantibodies against the prion protein in individuals with PRNP mutations

<p><span><span><span><span><span><span><span><span><span><span><span><i>Objective. </i>To determine whether naturally occurring autoantibodies against the prion protein are present in individuals with genetic prion disease mutations and controls, and if so, whether they are protective against prion disease. </span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><i>Methods. </i>In this case-control study, we collected 124 blood samples from individuals with a variety of pathogenic<i>PRNP</i>mutations and 78 control individuals with a positive family history of genetic prion disease but lacking disease-associated<i>PRNP</i>mutations. Antibody reactivity was measured using an indirect ELISA for the detection of human IgG<sub>1-4 </sub>antibodies against wild-type human prion protein. Multivariate linear regression models were constructed to analyze differences in autoantibody reactivity between a) <i>PRNP</i>mutation carriers versus controls and b) asymptomatic versus symptomatic <i>PRNP</i>mutation carriers. Robustness of results was examined in matched cohorts.</span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><i>Results. </i>We found that antibody reactivity was present in a subset of both <i>PRNP</i>mutation carriers and controls. Autoantibody levels were not influenced by <i>PRNP </i>mutation status nor clinical manifestation of prion disease. <i>Post hoc</i>analyses showed anti-PrP<sup>C</sup>autoantibody titers to be independent of personal history of autoimmune disease and other immunological disorders, as well as <i>PRNP</i>codon 129 polymorphism. </span></span></span></span></span></span></span></span></span></span></span></p> <p><span><span><span><span><span><span><span><span><span><span><span><i>Conclusions.</i>Pathogenic <i>PRNP</i>variants do not notably stimulate antibody-mediated anti-PrP<sup>C</sup>immunity. Anti-PrP<sup>C</sup>IgG autoantibodies are not associated with the onset of prion disease. The presence of anti-PrP<sup>C</sup>autoantibodies in the general population without any disease-specific association suggests that relatively high titers of naturally occurring antibodies are well tolerated. Clinicaltrials.gov identifier NCT02837705. </span></span></span></span></span></span></span></span></span></span></span></p>

opencc-zeroDec 2020View details →
ClinicalTrials.gov32/100

Characterization of Human Autoantibody Titers After Central Nervous System Insult

ClinicalTrials.gov study NCT03089749. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Phospholipase A2 Receptor (PLA2R1) Autoantibodies in Membranous Nephropathy in Kidney Transplantation

ClinicalTrials.gov study NCT01897961. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma

ClinicalTrials.gov study NCT00814827. IPD Sharing: YES. Countries: 3. Publications: 4.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Autoantibody Specificity and Response to IVIG in ITP

ClinicalTrials.gov study NCT01666795. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Autoantibodies and Direct-acting Antivirals

ClinicalTrials.gov study NCT03566966. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody

ClinicalTrials.gov study NCT00360763. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Autoantibodies on Spinal Cord Injury

ClinicalTrials.gov study NCT02493543. IPD Sharing: Not stated. Countries: 2. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Specific Autoantibody Testing in Patients With Interstitial Lung Disease

ClinicalTrials.gov study NCT01600352. IPD Sharing: Not stated. Countries: 1. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record